Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

Trisodium Citrate dihydrate

×

Overview

What is triCitrasol?

triCitrasol

Each 30 mL of contains:

pH adjusted with Citric Acid

pH: 6.3 – 6.6



What does triCitrasol look like?



What are the available doses of triCitrasol?

Sorry No records found.

What should I talk to my health care provider before I take triCitrasol?

Sorry No records found

How should I use triCitrasol?

triCitrasol

triCitrasol

triCitrasol

The /HES solution is stable for up to 24 hours at room temperature after mixing.

Refer to the manufacturer's Operator's Manual of the apheresis medical device for the directions to perform the granulocytapheresis procedure.

The apheresis system will control the amount of the citrate/6% solution of HES that is added to the whole blood and the method of administration of the solution. Refer to the Operator's Manual of the apheresis medical device.


What interacts with triCitrasol?

NOT FOR DIRECT INTRAVENOUS INFUSION.



What are the warnings of triCitrasol?

Array


What are the precautions of triCitrasol?

General

Aseptic technique must be maintained at all times.

triCitrasol

The cap/stopper system provides a biological barrier and should be intact – discard product if system is comprised.

Information for Patients

None.

Laboratory Tests

There are no laboratory tests for the drug product at this time.

Drug Interactions

There are no adverse reactions for the addition of the product to the rouleaux agent.

Carcinogenesis, mutagenesis, impairment of fertility

Long-term studies in animals have not been performed to evaluate the carcinogenic potential of .

Pregnancy

Long-term studies in animals have not been performed to evaluate the effects of on pregnant women.

Pediatric Use

The safety and effectiveness of in children have not been established.


What are the side effects of triCitrasol?

Citrate reactions or toxicity may occur with the infusion of blood products containing citrate anticoagulant . The recipient of the citrated blood product should be monitored for the signs and symptoms of citrate toxicity . The signs and symptoms of citrate toxicity begin with paresthesia, a "tingling" sensation around the mouth or in the extremities, followed by severe reactions that are characterized by chills, stomach cramps, or pressure in the chest, followed by more severe reactions that are characterized by hypotension and possible cardiac arrhythmia . Citrate toxicity may occur more frequently in patients that are hypothermic , have impaired liver or renal function , or have low calcium levels because of an underlying disease .


What should I look out for while using triCitrasol?

NOT FOR DIRECT INTRAVENOUS INFUSION.

CONCENTRATED ANTICOAGULANT – DILUTE PRIOR TO USE.


What might happen if I take too much triCitrasol?

Since the bottle of contains only 30mL of the product, it is impossible to overdose the addition of the product to the 6% solution of HES. However, in the event of a reaction to the infusion of citrated blood products, evaluate the patient and institute appropriate corrective actions .


How should I store and handle triCitrasol?

triCitrasol®triCitrasol®


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

A sodium citrate solution acts as an anticoagulant by the action of the citrate ion chelating free ionized calcium; thus, the calcium ion is unavailable to the coagulation system .

Non-Clinical Toxicology
NOT FOR DIRECT INTRAVENOUS INFUSION.

CONCENTRATED ANTICOAGULANT – DILUTE PRIOR TO USE.

There are no adverse reactions for the addition of the product to the rouleaux agent.

Aseptic technique must be maintained at all times.

triCitrasol

The cap/stopper system provides a biological barrier and should be intact – discard product if system is comprised.

Citrate reactions or toxicity may occur with the infusion of blood products containing citrate anticoagulant . The recipient of the citrated blood product should be monitored for the signs and symptoms of citrate toxicity . The signs and symptoms of citrate toxicity begin with paresthesia, a "tingling" sensation around the mouth or in the extremities, followed by severe reactions that are characterized by chills, stomach cramps, or pressure in the chest, followed by more severe reactions that are characterized by hypotension and possible cardiac arrhythmia . Citrate toxicity may occur more frequently in patients that are hypothermic , have impaired liver or renal function , or have low calcium levels because of an underlying disease .

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

This medication has worked for me.




This medication has been easy for me to use.




Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).